
IndraLab
Statements
reach
"In contrast, FOXO3a was reported to inhibit the expression beta-catenin by transactivating miR-34b/c in prostate cancer [XREF_BIBR], and FOXO3a can directly bind to beta-catenin and compete with T cell factor (TCF) for the interaction to beta-catenin, thereby inhibiting beta-catenin and TCF transcriptional activity [XREF_BIBR]."